Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 4, 2014, Pages 368-381

  Shiba, Yuji ^a,b   Filice, Dominic ^a,c   Fernandes, Sarah ^a,d   Minami, Elina ^a   Dupras, Sarah K ^a   Van Biber, Benjamin ^a   Trinh, Peter ^a   Hirota, Yusuke ^b   Gold, Joseph D ^e,f   Viswanathan, Mohan ^a   Laflamme, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SHINSHU UNIVERSITY   (Japan)

^c University of Washington   (United States)

^d Gilead Sciences   (United States)

^e GERON CORPORATION   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Cardiomyocyte; Cell transplantation; Electrophysiology; Human embryonic stem cell (hESC)

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; COLD INJURY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROSTIMULATION; EMBRYONIC STEM CELL; GRAFT RECIPIENT; GUINEA PIG; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 84904756250     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413520344     Document Type: Article

References (43)

1. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25(9):1015-1024. (Pubitemid 47517637)
2. Caspi O, Huber I, Kehat I, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007;50(19):1884-1893. (Pubitemid 350007960)
3. van Laake LW, Passier R, Monshouwer Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007;1(1):9-24. (Pubitemid 350251944)
4. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet. 2005; 366(9490):1005-1012. (Pubitemid 41323036)
5. Blin G, Nury D, Stefanovic S, et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest. 2010;120(4):1125-1139.
6. Chen HS, Kim C, Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation. 2009;120(24): 2496-2508.
7. Gepstein L. Electrophysiologic implications of myocardial stem cell therapies. Heart Rhythm. 2008;5(6 suppl):S48-S52.
8. Jonsson MK, Duker G, Tropp C, et al. Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 2010;4(3):189-200.
9. Liao SY, Liu Y, Siu CW, et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm. 2010;7(12):1852-1859.
10. Zhang YM, Hartzell C, Narlow M, Dudley SC Jr. Stem cellderived cardiomyocytes demonstrate arrhythmic potential. Circulation. 2002;106(10):1294-1299. (Pubitemid 34988651)
11. Shiba Y, Fernandes S, Zhu WZ, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 2012;489(7415):322-325.
12. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature. 2007;450(7171):819-824. (Pubitemid 350237591)
13. Thompson SA, Burridge PW, Lipke EA, Shamblott M, Zambidis ET, Tung L. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J Mol Cell Cardiol. 2012;53(1):15-23.
14. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22(10):1282-1289. (Pubitemid 39341201)
15. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation. 2005;111(1):11-20. (Pubitemid 40070838)
16. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol. 2010;49(6):941-949.
17. Xu C, Police S, Hassanipour M, et al. Efficient generation and cryopreservation of cardiomyocytes from human embryonic stem cells. Regen Med. 2011;6(1):53-66.
18. Xu C, InokumaMS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001; 19(10):971-974. (Pubitemid 32947578)
19. Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng. 2005;91(6):688-698. (Pubitemid 41283861)
20. Zhu WZ, Van Biber B, Laflamme MA.Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods Mol Biol. 2011; 767:419-431.
21. Walker MJ, Curtis MJ, Hearse DJ, et al. The lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988;22(7):447-455.
22. Hockemeyer D, Soldner F, Beard C, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009;27(9):851-857.
23. Laflamme MA, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol. 2005;167(3):663-671. (Pubitemid 41216352)
24. Dvir T, Kedem A, Ruvinov E, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A. 2009;106(35):14990-14995.
25. Ang KL, Shenje LT, Reuter S, et al. Limitations of conventional approaches to identify myocyte nuclei in histologic sections of the heart. Am J Physiol Cell Physiol. 2010;298(6): C1603-C1609.
26. Nizheradze KA. Binding of wheat germ agglutinin to extracellular network produced by cultured human fibroblasts. Folia Histochem Cytobiol. 2000;38(4):167-173.
27. Ohno J, Tajima Y, Utsumi N. Binding of wheat germ agglutinin in the matrix of rat tracheal cartilage. Histochem J. 1986;18(10): 537-540. (Pubitemid 17223023)
28. van Laake LW, van Donselaar EG, Monshouwer-Kloots J, et al. Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci. 2010;67(2):277-290.
29. Shiotani M, Harada T, Abe J, Hamada Y, Horii I. Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs. J Pharmacol Toxicol Methods. 2007; 55(1):27-34. (Pubitemid 46048677)
30. Shiotani M, Harada T, Abe J, et al. Practical application of guinea pig telemetry system for QT evaluation. J Toxicol Sci. 2005; 30(3):239-247. (Pubitemid 41305781)
31. Mills WR, Mal N, Kiedrowski MJ, et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol. 2007;42(2):304-314. (Pubitemid 46135598)
32. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11): 1204-1219.
33. Pak HN, Qayyum M, Kim DT, et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol. 2003;14(8):841-848. (Pubitemid 36994105)
34. Ieda M, Kimura K, Kanazawa H, Fukuda K. Regulation of cardiac nerves: a new paradigm in the management of sudden cardiac death? Curr Med Chem. 2008;15(17):1731-1736.
35. Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J. 2007;21(7):1345-1357. (Pubitemid 46684837)
36. Swijnenburg RJ, Schrepfer S, Cao F, et al. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev. 2008;17(6): 1023-1029.
37. van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res. 2008;102(9):1008-1010. (Pubitemid 351667854)
38. Christoffels VM, Pu WT. Developing insights into cardiac regeneration. Development. 2013;140(19):3933-3937.
39. Halbach M, Pfannkuche K, Pillekamp F, et al. Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res. 2007;101(5):484-492. (Pubitemid 47347879)
40. Pillekamp F, Reppel M, Rubenchyk O, et al. Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells. 2007;25(1): 174-180. (Pubitemid 46052988)
41. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21(10): 737-746. (Pubitemid 17144243)
42. van den Bos EJ, Mees BM, de Waard MC, de Crom R, Duncker DJ. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am J Physiol Heart Circ Physiol. 2005;289(3):H1291-H1300. (Pubitemid 41208975)
43. Ciulla MM, Paliotti R, Ferrero S, et al. Left ventricular remodeling after experimental myocardial cryoinjury in rats. J Surg Res. 2004;116(1):91-97. (Pubitemid 38083289)